Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara L Gale

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Spatial and Spatio-Temporal Epidemiology|July 4, 2012
Crime, neighborhood deprivation, and asthma: a GIS approach to define and assess neighborhoodsSara L Gale, Sheryl L Magzamen, John D Radke, et al.
Rheumatology and Therapy|November 18, 2019
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims PopulationSara L Gale, Huong Trinh, Nitya Mathew, et al.
Preventive Medicine Reports|June 6, 2018
Optimizing community-level surveillance data for pediatric asthma managementWande O Benka-Coker, Sara L Gale, Sylvia J Brandt, et al.
Journal of Exposure Science & Environmental Epidemiology|May 3, 2012
Polycyclic aromatic hydrocarbon exposure and wheeze in a cohort of children with asthma in Fresno, CASara L Gale, Elizabeth M Noth, Jennifer Mann, et al.
Annals of the Rheumatic Diseases|May 7, 2018
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaborationKim Lauper, Dan C Nordström, Karel Pavelka, et al.
Seminars in Arthritis and Rheumatism|July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritisKim Lauper, Denis Mongin, Florenzo Iannone, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Spatial and Spatio-Temporal Epidemiology|July 4, 2012
Crime, neighborhood deprivation, and asthma: a GIS approach to define and assess neighborhoodsSara L Gale, Sheryl L Magzamen, John D Radke, et al.
Rheumatology and Therapy|November 18, 2019
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims PopulationSara L Gale, Huong Trinh, Nitya Mathew, et al.
Preventive Medicine Reports|June 6, 2018
Optimizing community-level surveillance data for pediatric asthma managementWande O Benka-Coker, Sara L Gale, Sylvia J Brandt, et al.
Journal of Exposure Science & Environmental Epidemiology|May 3, 2012
Polycyclic aromatic hydrocarbon exposure and wheeze in a cohort of children with asthma in Fresno, CASara L Gale, Elizabeth M Noth, Jennifer Mann, et al.
Annals of the Rheumatic Diseases|May 7, 2018
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaborationKim Lauper, Dan C Nordström, Karel Pavelka, et al.
Seminars in Arthritis and Rheumatism|July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritisKim Lauper, Denis Mongin, Florenzo Iannone, et al.
Pageof 1